Both companies have cited safety concerns as the reason for blocking compounding, although they both have a clear financial concern in the matter as well
Other causes include stress, hormonal changes, scalp infections, Alopecia Areata, hair-pulling disorders, other associated skin diseases, certain medications, Radiotherapy, Chemotherapy etc
The FDA has expressed concern with direct-to-consumer marketing across the pharmaceutical industry and an intent to more aggressively enforce laws that require fair balance between a products risks and benefits
Track every lab.Keep the whole picture
And as we're seeing the influence of these big trials, this is why many cardiology guidelines are now considering GLP ones in high risk patients